Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial.

Sabine AltrichterAna Maria Giménez-ArnauJonathan A BernsteinMartin MetzLila BahadoriMaria BergquistLaura BrooksCalvin N HoPriya JainPradeep B LukkaEva Rodriguez-SuárezClaire WaltonCatherine J Dattonull null

Published in: The British journal of dermatology (2024)

Although benralizumab resulted in near-complete depletion of blood eosinophils, there was no clinical benefit over placebo.

Keyphrases

placebo controlled
double blind
phase iii
phase ii
study protocol
clinical trial
open label
phase ii study
randomized controlled trial
radiation therapy